Karnataka’s heart attack data reveals lifestyle crisis in Bengaluru: Report

IMT News Desk
IMT News Desk
· 2 min read
pleased with closed eyes tilting head young girl on valentines day holding heart balloon isolated on white background

Research and observations from Jayadeva Institute of Cardiovascular Sciences and Research have revealed new risk factors in young patients, including abnormal lipoproteins, insulin resistance, and elevated homocysteine levels

Karnataka, as the first state in India to make sudden heart attack deaths “notifiable,” is in a unique position to study critical data and shed light on what’s causing heart disease in young Indians. The early results are alarming but unsurprising.

Research and observations from Jayadeva Institute of Cardiovascular Sciences and Research have revealed new risk factors in young patients, including abnormal lipoproteins, insulin resistance, and elevated homocysteine levels. This indicates that lifestyle habits such as unhealthy diets high in fats and carbohydrates, sugary beverages, smoking, and sedentary routines are major contributors.

For Bengaluru’s tech-driven workforce, these findings carry particular significance. The city’s fast-paced work culture, long hours, and high-stress environment create a perfect storm for cardiovascular risk, especially when combined with easy availability of processed foods.

“Karnataka’s groundbreaking data on abnormal lipoproteins and insulin resistance in young patients gives us a roadmap for prevention,” says Dr Vanita Rahman, a lifestyle medicine physician with the Physicians Committee for Responsible Medicine (PCRM). “Plant-based diets specifically target these biomarkers. We consistently see reductions in LDL cholesterol and significant improvements in insulin sensitivity within weeks. For the young professionals showing up in Karnataka’s cardiac disease statistics, shifting to diet rich in whole grains, fruits, vegetables, and legumes isn’t just healthier, it’s a targeted intervention against the exact factors this state is now tracking.”

The convenience factor compounds the problem. A recent PCRM survey found that 89% of Bengaluru residents had tried losing weight at least once, but only 27 per cent maintained long-term success. When asked about the biggest barrier to weight loss, 46 per cent pointed to the availability of unhealthy food, which is “too convenient and affordable.”

A landmark 15-year study following 123,330 women demonstrates plant-based protection potential. Women who most closely followed plant-focused eating patterns were 11 per cent less likely to develop cardiovascular disease overall, 14 per cent less likely to develop coronary heart disease, and 17 per cent less likely to develop heart failure.

As Karnataka continues collecting this vital data, the message for Bengaluru is clear: the state’s innovative tracking system has identified the problem – now the solution lies in addressing lifestyle factors driving premature heart disease through evidence-based dietary intervention.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk